indirubin-3'-monoxime has been researched along with Growth Disorders in 1 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, S | 1 |
| Cha, PH | 1 |
| Kim, HY | 1 |
| Choi, KY | 1 |
1 other study available for indirubin-3'-monoxime and Growth Disorders
| Article | Year |
|---|---|
Indirubin-3'-oxime stimulates chondrocyte maturation and longitudinal bone growth via activation of the Wnt/β-catenin pathway.
Topics: Animals; beta Catenin; Bone Development; Cell Differentiation; Cell Proliferation; Chondrocytes; Cho | 2019 |